Patents by Inventor Melvin G. McInnis

Melvin G. McInnis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Association of dopamine beta-hydroxylase polymorphisms with bipolar disorder
    Patent number: 6913885
    Abstract: A central role for the gene encoding dopamine beta-hydroxylase in neuropsychiatric disorders is disclosed. Use of single nucleotide polymorphisms in the dopamine beta-hydroxylase gene for diagnosis, prediction of clinical course and treatment response, development of new treatments and development of cell-culture based and animal models for research and treatment are disclosed.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: July 5, 2005
    Assignees: Whitehead Institute for Biomedical Research, Johns Hopkins University, The General Hospital Corporation
    Inventors: Pamela Sklar, Eric S. Lander, Melvin G. McInnis, J. Raymond DePaulo, Jr., Virginia Willour, James Potash
  • BDNF polymorphisms and association with bipolar disorder
    Publication number: 20030232365
    Abstract: Methods for diagnosing and treating neuropsychiatric disorders, especially bipolar disorder, and to methods for identifying compounds for use in the diagnosis and treatment of neuropsychiatric disorders are disclosed. Also disclosed are novel compounds and pharmaceutical compositions for use in the diagnosis and treatment of neuropsychiatric disorders such as bipolar disorder.
    Type: Application
    Filed: April 7, 2003
    Publication date: December 18, 2003
    Applicants: Whitehead Institute for Biomedical Research, Johns Hopkins University, The General Hospital Corporation
    Inventors: Pamela Sklar, Eric S. Lander, Melvin G. McInnis, J. Raymond DePaulo
  • BDNF polymorphism and association with bipolar disorder
    Publication number: 20030157493
    Abstract: Methods for diagnosing and treating neuropsychiatric disorders, especially bipolar disorder, and to methods for identifying compounds for use in the diagnosis and treatment of neuropsychiatric disorders are disclosed. Also disclosed are novel compounds and pharmaceutical compositions for use in the diagnosis and treatment of neuropsychiatric disorders such as bipolar disorder.
    Type: Application
    Filed: February 15, 2002
    Publication date: August 21, 2003
    Inventors: Pamela Sklar, Eric S. Lander, J. Raymond DePaulo, Melvin G. McInnis
  • Association of dopamine beta-hydroxylase polymorphisms with bipolar disorder
    Publication number: 20030027172
    Abstract: A central role for the gene encoding dopamine beta-hydroxylase in neuropsychiatric disorders is disclosed. Use of single nucleotide polymorphisms in the dopamine beta-hydroxylase gene for diagnosis, prediction of clinical course and treatment response, development of new treatments and development of cell-culture based and animal models for research and treatment are disclosed.
    Type: Application
    Filed: January 22, 2002
    Publication date: February 6, 2003
    Inventors: Pamela Sklar, Eric S. Lander, Melvin G. McInnis, J. Raymond DePaulo, Virginia Willour, James Potash
  • BDNF polymorphism and association with bipolar disorder
    Patent number: 6458541
    Abstract: Methods for diagnosing and treating neuropsychiatric disorders, especially bipolar disorder, and to methods for identifying compounds for use in the diagnosis and treatment of neuropsychiatric disorders are disclosed. Also disclosed are novel compounds and pharmaceutical compositions for use in the diagnosis and treatment of neuropsychiatric disorders such as bipolar disorder.
    Type: Grant
    Filed: August 11, 2000
    Date of Patent: October 1, 2002
    Assignees: Whitehead Institute for Biomedical Research, General Hospital Corporation, Johns Hopkins University
    Inventors: Pamela Sklar, Eric S. Lander, J. Raymond DePaulo, Melvin G. McInnis